Table 1.
Cold Cohort (n =134) | |
---|---|
Female, n (%) | 93 (69.4) |
| |
Race or ethnicity, n (%)† | |
White, non-Hispanic | 100 (74.6) |
Black, non-Hispanic | 19 (14.2) |
Hispanic | 8 (6.0) |
Other | 7 (5.2) |
| |
Age, years | 38.7 ± 11.7 |
| |
Subjects per center, n (%) | |
Boston | 25 (18.7) |
Denver | 18 (13.4) |
Madison | 29 (21.6) |
San Diego | 11 (8.2) |
San Francisco | 17 (12.7) |
Saint Louis | 16 (11.9) |
Winston-Salem | 18 (13.4) |
| |
Pre-bronchodilator FEV1 | |
Liters | 2.69 ± 0.73 |
% predicted | 80.0 ± 14.5 |
| |
Total serum IgE, IU/ml‡ | 99.6, 115 |
| |
Atopic, n (%)§ | 56 (96.6) |
| |
Prior tobacco use, n (%)† | 26 (19.4) |
| |
Entry mini-ACQ score ** | 1.04 ± 0.77 |
Plus-minus values are means ± standard deviation (SD)
Race, ethnicity, and prior tobacco use were self-reported
n = 132, reported as geometric mean and coefficient of variation (%)
n = 58
n = 125, scores can range from 0 (no symptoms) to 6 (severe symptoms)
Abbreviations: FEV1, forced expiratory volume in one second; IU, International Unit; ACQ, asthma control questionnaire.